Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Zandi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Neurology. Clinical Practice|February 15, 2018
Movement disorders and psychiatry: Five new thingsGemma Cummins, Michael Zandi, Roger A Barker
Movement Disorders Clinical Practice|July 10, 2025
Reply to "Neurophysiological Testing to Diagnose Stiff-Person Spectrum Disorder"João Moura, Lorenzo Rocchi, Michael Zandi, et al.
Movement Disorders Clinical Practice|January 8, 2025
Neurophysiological Insights into the Pathophysiology of Stiff-Person Spectrum DisordersJoão Moura, Lorenzo Rocchi, Michael Zandi, et al.
European Journal of Neurology|May 9, 2025
Cerebral Amyloid Angiopathy-Related Inflammation in Iatrogenic Cerebral Amyloid AngiopathyLarysa Panteleienko, Dermot Mallon, Cho Me Me Htet, et al.
European Journal of Neurology|October 5, 2023
Mental health outcomes of encephalitis: An international web-based studyMatt Butler, Yasmin Abdat, Michael Zandi, et al.
The Lancet. Neurology|April 14, 2023
Chronic effects of inflammation on tauopathiesConnor Langworth-Green, Saisha Patel, Zane Jaunmuktane, et al.
Annals of Neurology|September 19, 2025
Clinical-Radiological Spectrum of Cerebral Amyloid Angiopathy-Related InflammationLarysa Panteleienko, Gargi Banerjee, Dermot Mallon, et al.
Neuroimage. Clinical|September 1, 2017
Disrupted avoidance learning in functional neurological disorder: Implications for harm avoidance theoriesLaurel S Morris, Benjaman To, Kwangyeol Baek, et al.
BMJ Open|January 14, 2026
Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysisJai Prashar, Toby Hillman, Emma C Wall, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neurology. Clinical Practice|February 15, 2018
Movement disorders and psychiatry: Five new thingsGemma Cummins, Michael Zandi, Roger A Barker
Movement Disorders Clinical Practice|July 10, 2025
Reply to "Neurophysiological Testing to Diagnose Stiff-Person Spectrum Disorder"João Moura, Lorenzo Rocchi, Michael Zandi, et al.
Movement Disorders Clinical Practice|January 8, 2025
Neurophysiological Insights into the Pathophysiology of Stiff-Person Spectrum DisordersJoão Moura, Lorenzo Rocchi, Michael Zandi, et al.
European Journal of Neurology|May 9, 2025
Cerebral Amyloid Angiopathy-Related Inflammation in Iatrogenic Cerebral Amyloid AngiopathyLarysa Panteleienko, Dermot Mallon, Cho Me Me Htet, et al.
European Journal of Neurology|October 5, 2023
Mental health outcomes of encephalitis: An international web-based studyMatt Butler, Yasmin Abdat, Michael Zandi, et al.
The Lancet. Neurology|April 14, 2023
Chronic effects of inflammation on tauopathiesConnor Langworth-Green, Saisha Patel, Zane Jaunmuktane, et al.
Annals of Neurology|September 19, 2025
Clinical-Radiological Spectrum of Cerebral Amyloid Angiopathy-Related InflammationLarysa Panteleienko, Gargi Banerjee, Dermot Mallon, et al.
Neuroimage. Clinical|September 1, 2017
Disrupted avoidance learning in functional neurological disorder: Implications for harm avoidance theoriesLaurel S Morris, Benjaman To, Kwangyeol Baek, et al.
BMJ Open|January 14, 2026
Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysisJai Prashar, Toby Hillman, Emma C Wall, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Pageof 2